JP2024540318A5 - - Google Patents
Info
- Publication number
- JP2024540318A5 JP2024540318A5 JP2024526654A JP2024526654A JP2024540318A5 JP 2024540318 A5 JP2024540318 A5 JP 2024540318A5 JP 2024526654 A JP2024526654 A JP 2024526654A JP 2024526654 A JP2024526654 A JP 2024526654A JP 2024540318 A5 JP2024540318 A5 JP 2024540318A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB202116077 | 2021-11-09 | ||
| GB2116077.5 | 2021-11-09 | ||
| PCT/GB2022/052833 WO2023084206A1 (en) | 2021-11-09 | 2022-11-09 | N-(4-aminocyclohexyl)pyrimidine-4-carboxamide derivatives as cd38 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024540318A JP2024540318A (ja) | 2024-10-31 |
| JPWO2023084206A5 JPWO2023084206A5 (https=) | 2025-11-18 |
| JP2024540318A5 true JP2024540318A5 (https=) | 2025-11-18 |
Family
ID=84360092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526654A Pending JP2024540318A (ja) | 2021-11-09 | 2022-11-09 | Ｃｄ３８阻害剤としてのｎ－（４－アミノシクロヘキシル）ピリミジン－４－カルボキサミド誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250019369A1 (https=) |
| EP (1) | EP4430034A1 (https=) |
| JP (1) | JP2024540318A (https=) |
| CN (1) | CN118317955A (https=) |
| CA (1) | CA3236793A1 (https=) |
| WO (1) | WO2023084206A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023235880A1 (en) * | 2022-06-02 | 2023-12-07 | Aeovian Pharmaceuticals, Inc. | Cd38 modulators and uses thereof |
| AU2024285368A1 (en) * | 2023-06-07 | 2025-12-18 | Flagship Pioneering Innovations Vi, Llc | Condensed azines as inhibitors of cyclic adp ribose hydrolase |
| WO2026000074A1 (en) * | 2024-06-25 | 2026-01-02 | Welnx Company Inc. | Use of cd38 inhibitors for reducing th2 inflammation |
| WO2026075971A1 (en) | 2024-10-01 | 2026-04-09 | Neolaia Inc. | Combination therapy for treatment of metabolic disorders and inflamation related disorders using incretin compounds and cd38 inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021021986A1 (en) | 2019-07-31 | 2021-02-04 | Ribon Therapeutics, Inc. | Heterobicyclic amides as inhibitors of cd38 |
| BR112022020291A2 (pt) * | 2020-04-07 | 2022-12-06 | Mitobridge Inc | Inibidores de cd38 |
| US20240254113A1 (en) * | 2021-04-30 | 2024-08-01 | Nanjing Immunophage Biotech Co., Ltd. | Compounds and their uses as cd38 inhibitors |
-
2022
- 2022-11-09 CA CA3236793A patent/CA3236793A1/en active Pending
- 2022-11-09 EP EP22805932.5A patent/EP4430034A1/en active Pending
- 2022-11-09 JP JP2024526654A patent/JP2024540318A/ja active Pending
- 2022-11-09 US US18/708,486 patent/US20250019369A1/en active Pending
- 2022-11-09 WO PCT/GB2022/052833 patent/WO2023084206A1/en not_active Ceased
- 2022-11-09 CN CN202280073666.2A patent/CN118317955A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540318A5 (https=) | ||
| BR102022025291A2 (https=) | ||
| CL2025004149A1 (es) | Método y sistema para la recuperación de elementos valiosos a partir de la materia prima derivada de los relaves de minas de cobre. | |
| CL2025003721S1 (es) | Rampa con dos bloques maniobras vehiculares. | |
| BR102022023461A2 (https=) | ||
| BY13174U (https=) | ||
| BY23965C1 (https=) | ||
| CN307047316S (https=) | ||
| CN307047111S (https=) | ||
| CN307046759S (https=) | ||
| CN307046546S (https=) | ||
| CN307045861S (https=) | ||
| CN307045607S (https=) | ||
| CN307045573S (https=) | ||
| CN307045405S (https=) | ||
| CN307045121S (https=) | ||
| CN307044758S (https=) | ||
| CN307044557S (https=) | ||
| BY13167U (https=) | ||
| CN307044377S (https=) | ||
| BY13168U (https=) | ||
| BY23963C1 (https=) | ||
| BY13176U (https=) | ||
| BY13175U (https=) | ||
| BY13160U (https=) |